BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Management Buyout of Winner Medical - Shareholder Investigation by Tripp Levy PLLC on Behalf of Winner Medical Group Shareholders


4/2/2012 1:27:57 PM

NEW YORK, April 2, 2012 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities law firm, is investigating the Board of Directors of Winner Medical Group Inc. ("Winner" or the "Company") (Nasdaq:WWIN) for possible breaches of fiduciary duty and other violations of state law in connection with the receipt of a going private proposal from its Chairman and Chief Executive Officer, Mr. Jianquan Li. According to the terms of the proposal, Li would acquire all outstanding shares of the Company's common stock for $4.30 per share. Li currently owns approximately 74% of the Company's stock.

The investigation concerns, among other things, whether the consideration to be paid to Winner shareholders is unfair, inadequate, and substantially below the fair or inherent value of Winner, and whether Li is a controlling shareholder that is taking advantage of his position to purchase the Company at an unfair price. Indeed, analysts project the stock of Winner is worth at least $6.27 per share, and the company's book value alone is $5.31 per share.

If you own common stock in Winner and wish to obtain additional information, please contact us at:

Tripp Levy PLLC

Toll free: 877-772-3975

Email: contact@tripplevy.com

www.tripplevy.com

SOURCE Tripp Levy PLLC



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES